中国癌症杂志2024,Vol.34Issue(1) :1-13.DOI:10.19401/j.cnki.1007-3639.2024.01.001

2023年度胰腺癌研究及诊疗新进展

Advances in basic research,clinical diagnosis and treatment of pancreatic cancer in 2023

李天骄 叶龙云 金凯舟 吴伟顶 虞先濬
中国癌症杂志2024,Vol.34Issue(1) :1-13.DOI:10.19401/j.cnki.1007-3639.2024.01.001

2023年度胰腺癌研究及诊疗新进展

Advances in basic research,clinical diagnosis and treatment of pancreatic cancer in 2023

李天骄 1叶龙云 1金凯舟 1吴伟顶 1虞先濬1
扫码查看

作者信息

  • 1. 复旦大学附属肿瘤医院胰腺外科,复旦大学上海医学院肿瘤学系,复旦大学胰腺肿瘤研究所,上海市胰腺肿瘤研究所,上海 200032
  • 折叠

摘要

胰腺癌是恶性程度极高的消化系统肿瘤,其症状隐匿、治疗手段有限、进展迅速.随着胰腺癌的发病率逐年上升,胰腺癌越来越成为危害公共健康的突出问题,造成了巨大的社会负担.尽管胰腺癌患者的生存率在最近20余年并无明显改善,但目前在胰腺癌领域中,流行病学、基础和临床研究明显加速,有些研究成果已使一小部分胰腺癌患者取得更好的生存获益.本文就2023年度胰腺癌研究及诊疗的重大进展进行综述.

Abstract

Pancreatic cancer is a highly malignant digestive tract tumor with hidden symptoms,limited treatment options and rapid progression.With an increasing incidence rate year by year,pancreatic cancer has increasingly become a prominent issue endangering public health,causing a huge social burden.Although there was no significant improvement in survival rates for pancreatic cancer patients in the past two decades,recent progress in epidemiology,basic research and clinical research of pancreatic cancer has accelerated significantly compared to the past.Some findings have already enabled a small proportion of pancreatic cancer patients to achieve better survival.This article provided a review of the significant progress made in research,diagnosis and treatment of pancreatic cancer in 2023.

关键词

胰腺癌/流行病学/基础研究/临床研究

Key words

Pancreatic cancer/Epidemiology/Basic research/Clinical research

引用本文复制引用

基金项目

国家自然科学基金(U21A20374)

国家自然科学基金(82173091)

出版年

2024
中国癌症杂志
复旦大学附属肿瘤医院

中国癌症杂志

CSTPCDCSCD北大核心
影响因子:2.015
ISSN:1007-3639
参考文献量1
段落导航相关论文